Figures
Abstract
Importance
Cigarette smoking increases the risk of surgery in Crohn’s disease. However, the effect of smoking on the need for surgery for diverticulitis is unknown.
Objective
We evaluated whether smoking was a risk factor for surgery among patients admitted to hospital with acute diverticulitis.
Design
We conducted a population-based comparative cohort study of patients admitted to hospital for diverticulitis who were treated with medical versus surgical management.
Setting & Participants
We used the population-based Discharge Abstract Database to identify 176 adults admitted emergently with a diagnosis of diverticulitis between 2009 and 2010 in Calgary.
Intervention & Main Outcome
We performed a medical chart review to confirm the diagnosis of diverticulitis and to extract clinical data. The primary outcome was a partial colectomy during hospitalization. Logistic regression evaluated the association between smoking and surgery after adjusting for potential confounders, including age, sex, comorbidity, and disease severity.
Results
A partial colectomy was performed on 35.6% of patients with diverticulitis and 1.3% died. Among diverticulitis patients, 26.8% were current smokers, 31.5% were ex-smokers, and 41.6% never smoked. Compared to non-smokers, current smokers (adjusted odds ratio [OR] 9.02; 95% confidence interval [CI]: 2.47–32.97) and former smokers (adjusted OR 5.41; 95% CI: 1.54–18.96) had increased odds of surgery.
Citation: Diamant MJ, Schaffer S, Coward S, Kuenzig ME, Hubbard J, Eksteen B, et al. (2016) Smoking Is Associated with an Increased Risk for Surgery in Diverticulitis: A Case Control Study. PLoS ONE 11(7): e0153871. https://doi.org/10.1371/journal.pone.0153871
Editor: Wan Yee Joseph Lau, The Chinese University of Hong Kong, HONG KONG
Received: December 16, 2015; Accepted: April 5, 2016; Published: July 28, 2016
Copyright: © 2016 Diamant et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: All aggregate level data is available in the manuscript and appendices. Individual data is not available for open access due to legal and ethics restrictions on patient privacy contained in the Health Information Act (http://www.health.alberta.ca/about/health-legislation.html). Data is derived from administrative data that is restricted by the data custodians: the Analytics unit of Alberta Health Services. The Alberta SPOR Support Unit can be contacted for information on access to this data, including appropriate ethical approval and data sharing agreements. To contact the Alberta SPOR Support Unit, visit their website at https://sporresources.researchalberta.ca/.
Funding: Shire Development LLC provided funding for the study. The funder provided support in the form of salary for Dr. Samuel Schaffer, who is an employee of Shire. Dr. Schaffer and the funder were involved in the following aspects of the study: study concept and design, interpretation of the data, and critical revision of the manuscript for important intellectual content. The manuscript was written by Drs. Diamant and Kaplan. Under the direction of the authors, Jason Jung, PhD, an employee of MedErgy, provided editorial assistance for this manuscript. Representatives from Shire also reviewed this manuscript for scientific accuracy. Shire Development LLC provided funding to MedErgy for support in editing this manuscript. The final content of this manuscript and the decision to submit it for publication were agreed upon by all authors.
Competing interests: Dr. Kaplan has served as a speaker for Janssen, Merck, Schering-Plough, Abbvie, and UCB Pharma and participated in advisory board meetings for Janssen, Abbvie, Merck, Schering- Plough, Shire, and UCB Pharma. He has received research support from Merck, Abbvie, Glaxo-Smith Kline, and Shire. Dr. Panaccione has served as a speaker, consultant, and advisory board member for Abbott, Merck, Schering-Plough, Shire, Centocor, Elan Pharmaceuticals, and Procter & Gamble. He has served as a consultant and speaker for AstraZeneca, a consultant and an advisory board member for Ferring Pharmaceuticals and UCB, a consultant for Glaxo-Smith Kline and Bristol-Myers Squibb, and a speaker for Byk Solvay, Axcan, Janssen, and Prometheus. He has received research funding from Merck, Schering-Plough, Abbott Laboratories, Elan Pharmaceuticals, Procter & Gamble, Bristol-Myers Squibb, and Millennium Pharmaceuticals and educational support from Merck, Schering-Plough, Ferring Pharmaceuticals, Axcan, and Janssen. Dr. Ghosh has served as a speaker for Merck, Schering-Plough, Centocor, Abbott, UCB Pharma, Pfizer, Ferring Pharmaceuticals, and Procter & Gamble and participated in ad hoc advisory board meetings for Centocor, Abbott, Merck, Schering-Plough, Proctor & Gamble, Shire, UCB Pharma, Pfizer, and Millennium. He has received research funding from Procter & Gamble, Merck, and Schering-Plough. Samuel Schaffer is an employee of Shire. Affiliation with Shire did not alter the authors' adherence to PLOS ONE policies on sharing data and materials. None of the competing interests declared altered the authors' adherence to PLOS ONE policies on sharing data and materials.
Background
Diverticulitis is increasing in incidence in North America[1]. The treatment of diverticulitis varies based on disease severity, with milder cases most commonly managed medically and severe, complicated, or life-threatening diverticulitis managed surgically[2]. Complications of diverticulitis include abscess or fistula formation, obstruction, bleeding, or perforation, and occur in approximately 15% to 20% of patients[3, 4]. Between 10% and 45% of patients with diverticulitis require surgery[5, 6], with an estimated 25% of patients requiring surgery during their initial hospital admission for diverticulitis[6].
Age has been shown to be a strong risk factor for the development of diverticulitis and younger age at diagnosis is associated with an increased risk of colectomy [7, 8]. However, regional variability in incidence rates[1] and racial disparities in peri-operative morbidity and mortality[9] suggest that environmental factors may influence the risk of developing diverticulitis and its prognosis.
While previous studies have examined the effect of smoking on the development of diverticulitis and its severity[10–18], the paucity of studies have led to uncertainty regarding smoking’s role in diverticulitis. Further, the effect of smoking on the need for surgery for diveriticulitis is not known. We hypothesize that smoking may also influence the need for surgery for diverticulitis.
The objectives of the study were to determine whether smoking was an independent risk factor for the need for surgical management of diverticulitis.
Methods
The Discharge Abstract Database (DAD) was received from the Data Integration Management and Reporting (DIMR) administrative healthcare database, which is a population-based administrative database [19]. The DAD includes all hospitalizations in the Calgary Health Zone of Alberta Health Services in Canada, a single-payer, public health authority encompassing approximately 1.3 million people. DAD captures the following characteristics: age, sex, area of residence (delineated from postal code), admission and discharge dates, admission type (emergent, urgent, or elective), transfer to or from hospitals, diagnostic and procedural codes, and hospital charges[23]. Diagnostic and procedural coding is based upon the International Classification of Disease, Tenth Revision, Clinical Modification and the Canadian Classification of Health Intervention, respectively. The use of DAD has been previously validated for tracking post-operative complications among ulcerative colitis patients[20].
We used the DAD to identify all patients admitted to hospital for diverticulitis in the Calgary Health Zone between April 1, 2009 and March 31, 2010. Chart review was also used to confirm the diagnosis of diverticulitis, assess whether patients received surgery during their admission, evaluate smoking status at admission, and extract relevant clinical data.
The primary outcome was a partial colectomy for the treatment of diverticulitis. The primary exposure was smoking status at admission to hospital, which was defined as current, former (no use in the past 30 days), or never smoker. Patients with missing data on smoking were excluded from the study population (n = 27). The following covariates were recorded from the medical chart: age at admission to hospital, sex, comorbidities, length of stay, and death in hospital. We assessed disease severity of diverticulitis as defined by Hinchey Classification[21], which categorizes diverticulitis severity as follows: I) localized abscess; II) pelvic abscess; III) purulent peritonitis; and IV) feculent peritonitis.
The Wilcoxon rank sum test was used to compare medians of continuous variables, the Fisher exact test was used to compare nominal categorical variables, and the ordinal categorical variables were compared using Cochran-Mantel-Haenszel row mean score statistics. All risk estimates are represented by adjusted odds ratios (OR) with 95% confidence intervals (CI) created using logistic regression. For all multivariable analyses, the primary outcome was colectomy and the primary exposure was smoking status defined as current, former, or never (referent). The model was adjusted for the following confounders: age, categorized as 18–39, 40–64, and ≥65 years old; sex; comorbidity index score [22], categorized as 0, 1–2, or >2 comorbidities; and Hinchey classification, categorized as II, III, or IV vs 0 and I (referent). A sensitivity analysis was conducted to evaluate the 27 patients with diverticulitis who did not have their smoking status recorded in their chart. For the sensitivity analysis we repeated the preceding regression analysis with the assumption that no record of smoking in the chart meant they were never smokers.
All statistical analyses were conducted using SAS, version 9.3 (SAS Institute Inc., Cary, NC, USA). In all instances an a priori α of 0.05 was used. The Conjoint Health Research Ethics Board (CHREB) at the University of Calgary approved the study protocol (Ethics ID: 23976). The CHREB approved a waiver of consent based on Section 50 of the Health Information Act on the grounds that obtaining consent was impractical.
Results
Among the 149 patients with diverticulitis and smoking status recorded in their chart, 53 (35.6%) underwent partial colectomy and 1.3% of patients died. Table 1 presents the disease characteristics stratified by need for surgery for diverticulitis. Those who required surgery had greater disease severity, more complicated diverticulitis, and longer length of stay as compared to those with medically managed diverticulitis (Table 1).
Among diverticulitis patients, 26.8% were current smokers, 31.5% were ex-smokers, and 41.6% never smoked. Compared to non-smokers, current smokers (adjusted OR 9.02, 95% CI: 2.47–32.97) and former smokers (adjusted OR 5.41, 95% CI: 1.54–18.96) had an increased odds of requiring surgery after adjusting for covariates including age (age 40–64 versus 18–39 years: adjusted OR = 0.61, 95% CI: 0.01–3.04) and Hinchey Disease Severity Classification (II, III, or IV versus 0 or I: adjusted OR 71.20, 95% CI: 14.98–338.33) (Table 2). A sensitivity analysis that assumed diverticulitis patients without smoking status recorded in their chart (n = 27) were never smokers yielded attenuated yet significant associations for current smokers (adjusted OR 4.72; 95% CI: 1.66–13.48) and former smokers (adjusted OR 3.39; 95% CI: 1.22–9.47) when compared to never smokers.
Discussion
This study demonstrated that current and former smokers were more likely than never smokers to require a partial colectomy to manage their diverticulitis following admission to hospital. By completing a chart review for each diverticulitis admission we confirmed the diagnosis of diverticulitis and the need for surgery. Further, we were able to ascertain smoking status at time of hospital admission assuring that smoking and quitting smoking preceded the admission to hospital for diverticulitis and the need for colectomy in management. Current smokers with diverticulitis had more than nine times the odds of requiring a partial colectomy as compared to never smokers. The strength of this association approximates the magnitude of associations for established risk factors such as smoking and lung cancer[23].
In order to objectively compare our findings to the literature, we conducted a systematic review of observational studies assessing the relationship between smoking and diverticulitis. A systematic literature search of MEDLINE (1950 to May 2, 2013) and EMBASE (Excerta Medica Database; 1980 to May 2, 2013) was conducted to identify studies examining the association between smoking and the risk of developing diverticulitis or the risk of needing surgery for diverticulitis. The included articles are summarized in Table 3. Three studies[12, 13, 15] found statistically significantly higher odds or proportions of patients developing complications of diverticulitis among smokers compared to non-smokers, whereas one study was not significant[14]. Additionally, three studies[11, 16, 18] found statistically significantly higher odds or proportions of developing diverticulitis itself among smokers compared to non-smokers. Also, a case-control study[10] found a higher number of pack-years smoked among patients who received surgical treatment for diverticulitis compared to those who did not, a finding that bordered on statistical significance. Lastly, a longitudinal, observational study found a slightly higher risk of recurrence among diverticulitis patients that smoked compared to those that did not, but this finding did not reach statistical significance [17]. Thus, the findings of our study are consistent with prior studies evaluating the effect of smoking on diverticulitis. Including our study, six of the ten observational studies have shown a statistically significant association between smoking status and diverticulitis development or other prognostic factors.
The effect of smoking and gastrointestinal diseases is well established. For example, Crohn’s disease is an analogous condition to diverticulitis that has been shown to be associated with smoking[24,25]. Smoking increases the risk of developing Crohn’s disease and is associated with a worse prognosis including early surgery and postoperative recurrence. Further, the prognosis of patients with Crohn’s disease who quit smoking over time will approximate that of patients who never smoked[26,27].
Several basic science studies have evaluated the mechanisms by which smoking may influence disease in the gastrointestinal tract. Smoking has been shown to reduce mucus production in the colon[28] and can impair endothelial function that can lead to relative mesenteric ischemia[29]. Additionally, smoking can alter the composition and diversity of the intestinal microbiome[30]. However, future studies specific to diverticulitis are necessary to explain the exact mechanism by which smoking may influence diverticulitis.
Observational studies of environmental risk factors are associated with inherent limitations that should be considered in our study[31]. Diverticulitis is a complicated disease with multiple phenotypes of clinical presentation and range of disease severity. Thus, multiple factors may influence the need for surgery. We adjusted the effect of smoking by disease severity; however, residual confounders may have not been evaluated (e.g., exposure to antibiotics and diet) due to lack of data in the medical charts. Also, the proportion of our population that underwent surgery was high (35.6%), suggesting that our study population reflected patients with high disease severity. Supporting this concern was the finding that 66% of our patients were under 65 years of age when they were admitted to hospital for diverticulitis. The young age of onset may have influenced the high rate of partial colectomies. Consequently, our findings are not necessarily generalizable to patients with milder diverticulitis such as patients managed without hospitalization. Further, we were reliant on the accuracy of data recorded in the chart and were not able to assess dose or duration of smoking. Further, approximately 15% of our cohort did not have data on smoking status recorded on their chart. However, our sensitivity analysis that assumed these individuals were non-smokers demonstrated attenuated yet significant associations for current and former smokers. Thus, future studies in different populations of diverticulitis patients are necessary to establish the consistency of smoking’s effects on diverticulitis.
Our observational study demonstrated temporality and a large strength of association. While the number and quality of prior studies is low, most of these studies demonstrated a positive association. Further, the effect of smoking on Crohn’s disease, a disease analogous to diverticulitis, has been established, including multiple basic science studies indicating biological plausibility. Thus, clinicians can use this information to advise their patients against the harm of smoking on diverticulitis. Gastroenterologists can also warn patients with diverticulosis that smoking may increase their risk of surgery if they develop an acute attack of diverticulitis. This data adds to the growing body of literature that highlights the harmful effects of smoking and will strengthen public policy initiatives to reduce smoking in the general population. In conclusion, smoking is an independent risk factor for the need for surgical management of diverticulitis.
Author Contributions
Conceived and designed the experiments: MJD SS SC GGK BE SH RP SG. Performed the experiments: SC MEK GGK. Analyzed the data: MJD JH GGK. Wrote the paper: MJD GGK SS SC MEK BE SH RP SG.
References
- 1. Nguyen GC, Sam J, Anand N. Epidemiological trends and geographic variation in hospital admissions for diverticulitis in the United States. World J Gastroenterol 2011;17:1600–5. pmid:21472127
- 2. Lopez DE, Brown CV. Diverticulitis: the most common colon emergency for the acute care surgeon. Scand J Surg 2010;99:86–9. pmid:20679043
- 3. Parks TG. Natural history of diverticular disease of the colon. Clin Gastroenterol 1975;4:53–9. pmid:1109820
- 4. Waugh JM, Walt AJ. Current trends in the surgical treatment of diverticulitis of the sigmoid colon. Surg Clin North Am 1962;42:1267–76. pmid:13999257
- 5. Parks TG, Connell AM. The outcome in 455 patients admitted for treatment of diverticular disease of the colon. Br J Surg 1970;57:775–8. pmid:5476757
- 6. Peppas G, Bliziotis IA, Oikonomaki D, Falagas ME. Outcomes after medical and surgical treatment of diverticulitis: a systematic review of the available evidence. J Gastroenterol Hepatol 2007;22:1360–8. pmid:17716342
- 7. Razik R, Chong CA, Nguyen GC. Younger age and prognosis in diverticulitis: a nationwide retrospective cohort study. Can J Gastroenterol 2013;27:95–8. pmid:23472245
- 8. Lahat A, Avidan B, Sakhnini E, Katz L, Fidder HH, Meir SB. Acute diverticulitis: a decade of prospective follow-up. J Clin Gastroenterol 2013;47:415–9. pmid:23328302
- 9. Alavi K, Cervera-Servin JA, Sturrock PR, Sweeney WB, Maykel JA. Racial differences in short-term surgical outcomes following surgery for diverticulitis. J Gastrointest Surg 2012;16:613–21. pmid:22125173
- 10. Yoo PS, Garg R, Salamone LF, Floch MH, Rosenthal R, Longo WE. Medical comorbidities predict the need for colectomy for complicated and recurrent diverticulitis. Am J Surg 2008;196:710–4. pmid:18954602
- 11. Usai P, Ibba I, Lai M, Boi MF, Savarese MF, Cuomo R, et al. Cigarette smoking and appendectomy: effect on clinical course of diverticulosis. Dig Liver Dis 2011;43:98–101. pmid:20579946
- 12. Turunen P, Wikström H, Carpelan-Holmström M, Kairaluoma P, Kruuna O, Scheinin T. Smoking increases the incidence of complicated diverticular disease of the sigmoid colon. Scand J Surg 2010;99:14–7. pmid:20501352
- 13. Papagrigoriadis S, Macey L, Bourantas N, Rennie JA. Smoking may be associated with complications in diverticular disease. Br J Surg 1999;86:923–6. pmid:10417566
- 14. Kim SY, Oh TH, Seo JY, Jeon TJ, Seo DD, Shin WC, et al. The clinical factors for predicting severe diverticulitis in Korea: a comparison with Western countries. Gut Liver 2012;6:78–85. pmid:22375175
- 15. Kakarla VR, Nurkin SJ, Sharma S, Ruiz DE, Tiszenkel H. Elective laparoscopic versus open colectomy for diverticulosis: an analysis of ACS-NSQIP database. Surg Endosc 2012;26:1837–42. pmid:22258301
- 16. Hjern F, Wolk A, Hakansson N. Smoking and the risk of diverticular disease in women. Br J Surg 2011;98:997–1002. pmid:21462366
- 17. Hall JF, Roberts PL, Ricciardi R, Read T, Scheirey C, Wald C, et al. Long-term follow-up after an initial episode of diverticulitis: what are the predictors of recurrence? Dis Colon Rectum 2011;54:283–8. pmid:21304297
- 18. Ahmed M, Lee T, Ha B. Acute diverticulitis and comorbidities. Am J Gastroenterol 2012;107:S213. (Abstract)
- 19. Lalonde AN, Taylor E. Medical classification systems in Canada: moving toward the year 2000. CMAJ 1997;157:1561–5. pmid:9400413
- 20. Ma C, Crespin M, Proulx MC, DeSilva S, Hubbard J, Prusinkiewicz M, et al. Postoperative complications following colectomy for ulcerative colitis: a validation study. BMC Gastroenterol 2012;12:39. pmid:22943760
- 21. Hinchey EJ, Schaal PG, Richards GK. Treatment of perforated diverticular disease of the colon. Adv Surg 1978;12:85–109. pmid:735943
- 22. Chalrson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373–83. pmid:3558716
- 23. Zang EA, Wynder EL. Differences in lung cancer risk between men and women: examination of the evidence. J Natl Cancer Inst 1996;88:183–92. pmid:8632492
- 24. Calkins BM. A meta-analysis of the role of smoking in inflammatory bowel disease. Dig Dis Sci 1989;34:1841–54. pmid:2598752
- 25. Molodecky NA, Kaplan GG. Environmental risk factors for inflammatory bowel disease. Gastroenterol Hepatol 2010;6:339–46.
- 26. Coward S, Heitman SJ, Clement F, Negron M, Panaccione R, Ghosh S, et al. Funding a smoking cessation program for Crohn’s disease: an economic evaluation. Am J Gastroenterol 2015 Mar; 110(3): 368–77. pmid:25350768
- 27. Frolkis A, Dieleman LA, Barkema HW, Panaccione R, Ghosh S, Fedorak RN, et al. Environment and the inflammatory bowel diseases. Can J Gastroenterol 2013;27:e18–24. pmid:23516681
- 28. Cope GF, Heatley RV, Kelleher JK. Smoking and colonic mucus in ulcerative colitis. Br Med J (Clin Res Ed) 1986;293:481.
- 29. Roifman I, Sun YC, Fedwick JP, Panaccione R, Buret AG, Liu H, et al. Evidence of endothelial dysfunction in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 2009;7:175–82. pmid:19121648
- 30. Benjamin JL, Hedin CR, Koutsoumpas A, Ng SC, McCarthy NE, Prescott NJ, et al. Smokers with active Crohn's disease have a clinically relevant dysbiosis of the gastrointestinal microbiota. Inflamm Bowel Dis 2012;18:1092–100. pmid:22102318
- 31. Molodecky NA, Panaccione R, Ghosh S, Barkema HW, Kaplan GG. Challenges associated with identifying the environmental determinants of the inflammatory bowel diseases. Inflamm Bowel Dis 2011;17:1792–9. pmid:21744435